Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

Many women with HIV in the North of England are diagnosed late and have other health conditions.

RNase L hinders hair growth by altering immune signals.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Upadacitinib effectively treats psoriasis and lichen planus together.

Effective delivery of gene editors is crucial for safe and successful gene editing in healthcare and agriculture.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Lichen planus pigmentosus may indicate undetected hepatitis C infection.

Nilotinib can cause keratosis pilaris, a skin condition.

Lupus pneumonitis can be misdiagnosed as pneumonia or tuberculosis, so consider lupus in similar cases for proper treatment.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

COVID-19 vaccination may trigger lupus in some people.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

A woman with hypothyroidism developed an allergy to IV levothyroxine after being resistant to oral forms.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Anifrolumab helped a woman with severe lupus achieve remission when other treatments failed.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

LncRNAs may help improve brain cancer treatment and diagnosis.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Lokivetmab reduced itching in a dog with skin lymphoma.

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.